Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
2.220
+0.010 (0.45%)
May 13, 2025, 4:59 PM SGT
SGX:T14 Revenue
Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.46B CNY in the quarter ending March 31, 2025, a decrease of -26.59%. This brings the company's revenue in the last twelve months to 6.68B, down -18.12% year-over-year. In the year 2024, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 7.31B, down -11.14%.
Revenue (ttm)
6.68B CNY
Revenue Growth
-18.12%
P/S Ratio
2.96
Revenue / Employee
1.45M CNY
Employees
4,619
Market Cap
3.65B SGD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.31B | -915.58M | -11.14% |
Dec 31, 2023 | 8.22B | -26.94M | -0.33% |
Dec 31, 2022 | 8.25B | 1.34B | 19.42% |
Dec 31, 2021 | 6.91B | 303.89M | 4.60% |
Dec 31, 2020 | 6.60B | -390.23M | -5.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition